• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Alset Capital Acquisition Corp.

    1/8/24 5:03:55 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care
    Get the next $ACAX alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 333-262152
    Issuer: Alset Capital Acquisition Corp.
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 4800 Montgomery LN, STE 210
    Bethesda MARYLAND 20814
    Telephone number: 301-971-3955
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Warrant, Right, Unit
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2024-01-08 By Tara Petta Director
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ACAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ACAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HWH International together with Alset Capital Acquisition Corp. Announce Closing of Business Combination

    The common stock of the combined company is expected to commence trading on The Nasdaq Global Market under ticker symbol "HWH" on January 9, 2024. Bethesda, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. ("Alset") (Nasdaq: "ACAX" for common stock and "ACAXR" for rights), today announced the completion of its previously announced business combination (the "Business Combination"), with HWH International Inc. ("HWH"), a purpose-driven lifestyle company encompassing differentiated offerings from four core pillars: HWH Marketplace, Hapi Cafe, Hapi Travel Destination and Hapi Wealth Builder. The common stock of the combined company is expected to begin trading on The Nasd

    1/8/24 12:20:00 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. Provides Additional Update Regarding Stockholder Redemptions

    Bethesda, MD, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. (NASDAQ:ACAX) ("Alset") provided additional updates today regarding stockholder redemptions. Alset currently has 1,911,236 shares of publicly held Class A common stock issued, outstanding and held by non-affiliates (such number of shares does not include any shares of Class A common stock held by Alset's Sponsor and management). Alset has extended the deadline for stockholders to redeem Class A common stock until 5:00 p.m. Eastern Time on Wednesday, September 13, 2023 ("the Revised Deadline"). In addition, stockholders who previously submitted redemption requests may withdraw such previously submitted redemp

    8/23/23 10:52:00 AM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. Provides Additional Update Regarding Stockholder Redemptions

    Bethesda, MD, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. (NASDAQ:ACAX) ("Alset") provided additional updates today regarding stockholder redemptions. Alset will be accepting requests by any public stockholder who submitted a request to redeem their Class A common stock prior to the deadline of July 28, 2023 to withdraw such previously submitted redemption requests until 5:00 p.m. Eastern Time on Wednesday, August 23, 2023. Stockholders who wish to withdraw their previously submitted redemption requests may do so by contacting Alset's transfer agent VStock Transfer, LLC at Attn: DWAC team, Email: [email protected]. About Alset Capital Acquisition Corp. Alset

    8/14/23 12:55:00 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    SEC Filings

    View All

    SEC Form 8-K filed by Alset Capital Acquisition Corp.

    8-K - HWH International Inc. (0001897245) (Filer)

    2/12/24 9:00:29 AM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - HWH International Inc. (0001897245) (Filer)

    1/12/24 5:22:46 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form 25-NSE filed by Alset Capital Acquisition Corp.

    25-NSE - Alset Capital Acquisition Corp. (0001897245) (Subject)

    1/8/24 5:03:55 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wolverine Asset Management Llc

    4 - HWH International Inc. (0001897245) (Issuer)

    1/12/24 12:04:38 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chan Heng Fai Ambrose disposed of 347,220 shares (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    2/1/24 9:45:27 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    New insider Alset Inc. claimed ownership of 13,577,375 shares (SEC Form 3)

    3 - HWH International Inc. (0001897245) (Issuer)

    1/19/24 7:57:05 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Chan Anthony S.

    3 - HWH International Inc. (0001897245) (Issuer)

    1/17/24 6:03:45 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Alset Capital Acquisition Corp.

    SC 13G - HWH International Inc. (0001897245) (Subject)

    2/14/24 4:59:56 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    2/14/24 3:30:10 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    2/14/24 12:26:24 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care